Clinical Trial Results: A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

View source ↗

Summary

Clinical trial evaluating safety and effectiveness of Pradaxa pellets in children aged 3 months to under 12 years with venous thromboembolism or at risk of recu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Pradaxa Pellets (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Thromboembolism | Status: TERMINATED | Results posted: 2026-06-02